15-98969533-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001167902.2(PGPEP1L):c.101G>A(p.Cys34Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0000248 in 1,614,024 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000015 ( 0 hom. )
Consequence
PGPEP1L
NM_001167902.2 missense
NM_001167902.2 missense
Scores
5
7
7
Clinical Significance
Conservation
PhyloP100: 6.32
Genes affected
PGPEP1L (HGNC:27080): (pyroglutamyl-peptidase I like) Predicted to enable pyroglutamyl-peptidase activity. Predicted to be involved in proteolysis. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.901
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PGPEP1L | NM_001167902.2 | c.101G>A | p.Cys34Tyr | missense_variant | 4/5 | ENST00000535714.2 | NP_001161374.1 | |
PGPEP1L | NM_001102612.2 | c.263G>A | p.Cys88Tyr | missense_variant | 4/5 | NP_001096082.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PGPEP1L | ENST00000535714.2 | c.101G>A | p.Cys34Tyr | missense_variant | 4/5 | 2 | NM_001167902.2 | ENSP00000437560.1 | ||
PGPEP1L | ENST00000378919.6 | c.263G>A | p.Cys88Tyr | missense_variant | 4/5 | 1 | ENSP00000368199.6 | |||
PGPEP1L | ENST00000637120.2 | c.329G>A | p.Cys110Tyr | missense_variant | 4/5 | 5 | ENSP00000490927.2 | |||
SYNM-AS1 | ENST00000559468.1 | n.267-3463G>A | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152248Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
14
AN:
152248
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000481 AC: 12AN: 249352Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135218
GnomAD3 exomes
AF:
AC:
12
AN:
249352
Hom.:
AF XY:
AC XY:
3
AN XY:
135218
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461658Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727112
GnomAD4 exome
AF:
AC:
22
AN:
1461658
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
727112
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000118 AC: 18AN: 152366Hom.: 1 Cov.: 33 AF XY: 0.000174 AC XY: 13AN XY: 74508
GnomAD4 genome
AF:
AC:
18
AN:
152366
Hom.:
Cov.:
33
AF XY:
AC XY:
13
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2024 | The c.263G>A (p.C88Y) alteration is located in exon 4 (coding exon 3) of the PGPEP1L gene. This alteration results from a G to A substitution at nucleotide position 263, causing the cysteine (C) at amino acid position 88 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;M;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;.
REVEL
Uncertain
Sift
Uncertain
D;D;.
Sift4G
Uncertain
D;D;.
Polyphen
1.0
.;D;.
Vest4
MutPred
0.77
.;Gain of phosphorylation at C88 (P = 0.0434);.;
MVP
MPC
0.38
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at